| PERIOD ENDING | 31-Jan-09 | 31-Jan-08 | 31-Jan-07 | | Total Revenue | 13,521 | 23,200 | 47,776 | | Cost of Revenue | 15,089 | 17,374 | 29,614 | | | Gross Profit | (1,568) | 5,826 | 18,162 | | | Operating Expenses | | Research Development | 2,843 | 8,799 | 7,989 | | Selling General and Administrative | 8,776 | 10,244 | 10,674 | | Non Recurring |
-
| 496 |
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | (13,187) | (13,713) | (501) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 113 | 3,139 | 2,628 | | Earnings Before Interest And Taxes | (13,074) | (10,574) | 2,127 | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | (13,074) | (10,574) | 2,127 | | Income Tax Expense | (3,375) | (590) | 350 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (9,699) | (9,984) | 1,777 | | | Non-recurring Events | | Discontinued Operations | 5,234 |
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (4,465) | (9,984) | 1,777 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($4,465) | ($9,984) | $1,777 |
|
0.03% Nasdaq 
0.05 (1.86%) 
Income Statement
